Literature DB >> 33873044

Trends over time in adult cannabis use: A review of recent findings.

Deborah Hasin1, Claire Walsh2.   

Abstract

In the United States, policies regarding the medical and nonmedical use of cannabis are changing rapidly. In 2021, a total of 34 US states have legalized cannabis for adult medical use, and 15 of these states have legalized adult non-medical use. These changing policies have raised questions about increasing prevalences of cannabis use, changing perceptions regarding frequent use, and potentially related outcomes such as comorbid psychiatric illness or driving under the influence of cannabis. Research regarding the correlates of any and frequent cannabis use is also developing quickly. This article reviews recent empirical studies concerning (1) adult trends in cannabis use, (2) state cannabis laws and related outcomes, and (3) emerging evidence regarding how the global coronavirus 19 pandemic may impact cannabis use patterns. We summarize recent findings and conclude with suggestions to address unanticipated effects of rapidly changing cannabis laws and policies.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adult trends; Cannabis; Cannabis use; Cannabis use disorder; MML; RML

Mesh:

Substances:

Year:  2021        PMID: 33873044      PMCID: PMC8905582          DOI: 10.1016/j.copsyc.2021.03.005

Source DB:  PubMed          Journal:  Curr Opin Psychol        ISSN: 2352-250X


  47 in total

1.  Recreational Cannabis - Minimizing the Health Risks from Legalization.

Authors:  Beau Kilmer
Journal:  N Engl J Med       Date:  2017-02-23       Impact factor: 91.245

2.  US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013.

Authors:  Deborah S Hasin; Aaron L Sarvet; Magdalena Cerdá; Katherine M Keyes; Malka Stohl; Sandro Galea; Melanie M Wall
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

3.  Considering marijuana legalization carefully: insights for other jurisdictions from analysis for Vermont.

Authors:  Jonathan P Caulkins; Beau Kilmer
Journal:  Addiction       Date:  2016-02-07       Impact factor: 6.526

4.  Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys.

Authors:  Wilson M Compton; Beth Han; Christopher M Jones; Carlos Blanco; Arthur Hughes
Journal:  Lancet Psychiatry       Date:  2016-08-31       Impact factor: 27.083

5.  Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.

Authors:  Arthur Robin Williams; Julian Santaella-Tenorio; Christine M Mauro; Frances R Levin; Silvia S Martins
Journal:  Addiction       Date:  2017-07-17       Impact factor: 6.526

6.  Cannabis use disorder and the lungs.

Authors:  Kathryn Gracie; Robert J Hancox
Journal:  Addiction       Date:  2020-04-28       Impact factor: 6.526

7.  Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys.

Authors:  Deborah S Hasin; Melanie Wall; Katherine M Keyes; Magdalena Cerdá; John Schulenberg; Patrick M O'Malley; Sandro Galea; Rosalie Pacula; Tianshu Feng
Journal:  Lancet Psychiatry       Date:  2015-06-15       Impact factor: 27.083

8.  Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.

Authors:  Lauren R Pacek; Andrea H Weinberger; Jiaqi Zhu; Renee D Goodwin
Journal:  Addiction       Date:  2019-12-20       Impact factor: 6.526

9.  Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence.

Authors:  Judith S Brook; Jung Yeon Lee; Stephen J Finch; Nathan Seltzer; David W Brook
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

10.  Home delivery of legal intoxicants in the age of COVID-19.

Authors:  Ellicott C Matthay; Laura A Schmidt
Journal:  Addiction       Date:  2020-11-26       Impact factor: 7.256

View more
  7 in total

Review 1.  Neural substrates of substance use disorders.

Authors:  Martin P Paulus
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

2.  Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic.

Authors:  Ryan D Assaf; Pamina M Gorbach; Ziva D Cooper
Journal:  Am J Drug Alcohol Abuse       Date:  2022-02-07       Impact factor: 3.912

3.  Differences in cannabis use characteristics, routines, and reasons for use among individuals with and without a medical cannabis card.

Authors:  Benjamin L Berey; Elizabeth R Aston; Nioud Mulugeta Gebru; Jennifer E Merrill
Journal:  Exp Clin Psychopharmacol       Date:  2022-01-13       Impact factor: 3.492

4.  Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.

Authors:  Gwen T Lapham; Theresa E Matson; David S Carrell; Jennifer F Bobb; Casey Luce; Malia M Oliver; Udi E Ghitza; Clarissa Hsu; Kendall C Browne; Ingrid A Binswanger; Cynthia I Campbell; Andrew J Saxon; Ryan Vandrey; Gillian L Schauer; Rosalie Liccardo Pacula; Michael A Horberg; Steffani R Bailey; Erin A McClure; Katharine A Bradley
Journal:  JAMA Netw Open       Date:  2022-05-02

5.  Two Models of Legalization of Psychedelic Substances: Reasons for Concern.

Authors:  William R Smith; Paul S Appelbaum
Journal:  JAMA       Date:  2021-08-24       Impact factor: 56.272

6.  Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices.

Authors:  Yasmina Hachem; Sara J Abdallah; Sergio Rueda; Jessica L Wiese; Kamna Mehra; Jennifer Rup; Juthaporn Cowan; Antonio Vigano; Cecilia T Costiniuk
Journal:  BMC Complement Med Ther       Date:  2022-09-08

7.  Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation.

Authors:  Maximilian Gahr; Julia Ziller; Ferdinand Keller; Rainer Muche; Ulrich W Preuss; Carlos Schönfeldt-Lecuona
Journal:  Eur J Public Health       Date:  2022-04-01       Impact factor: 3.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.